TMCI · Treace Medical Concepts, Inc. · Investor Relations
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-09-17 |
Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
PONTE VEDRA, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and other foot & ankle conditions, today announced the presentation of the |
| 2026-09-15 |
Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting
New product offerings extend bunion market leadership and accelerate penetration into new foot & ankle market adjacencies PONTE VEDRA, Fla., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a |
| 2026-08-07 |
Treace Medical Concepts Reports Second Quarter 2026 Financial Results
PONTE VEDRA, Fla., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related deformities, today reported financial results for the second |
| 2026-07-24 |
Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
PONTE VEDRA, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release |
| 2026-06-18 |
Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
New portfolio addition to drive further penetration into incremental procedures throughout the foot and ankle; strengthens Treace’s comprehensive suite of technologies for its growing customer base PONTE VEDRA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. |
| 2026-06-11 |
Treace to Present at the Sidoti Small Cap Conference
PONTE VEDRA, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will present at the |
| 2026-05-08 |
Treace Medical Concepts Reports First Quarter 2026 Financial Results
PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the |
| 2026-04-24 |
Treace to Report First Quarter 2026 Financial Results on May 8, 2026
PONTE VEDRA, Fla., April 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release |
| 2026-04-07 |
Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System
New portfolio addition taps into incremental procedures throughout the foot and ankle; strengthens Treace’s comprehensive suite of technologies for its growing customer base PONTE VEDRA, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: |
| 2026-02-27 |
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results
PONTE VEDRA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-07 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-18 | Sidoti Small Cap Conference | Conference |
| 2026-05-08 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-02-27 | Treace Medical Concepts Fourth Quarter and Full Year 2025 Earnings Conference Call | Earnings call |
| 2026-02-26 | Q4 FY2025 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-01-14 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-11-10 | UBS Global Healthcare Conference | Conference |
| 2025-11-06 | Treace Medical Concepts Third Quarter 2025 Earnings Conference Call | Earnings call |
| 2025-09-03 | Treace Medical Concepts, Inc. IR Day | Event |
| 2025-08-07 | Treace Medical Concepts Second Quarter 2025 Earnings Conference Call | Earnings call |
| 2025-05-08 | Treace Medical Concepts First Quarter 2025 Earnings Conference Call | Earnings call |
Source: https://investors.treace.com/